Oncology & Cancer

Identification of therapeutic targets in multiple myeloma

Multiple myeloma (MM) is a hematological cancer that frequently acquires resistance to chemotherapeutic drugs. Additionally, many patients experience disease relapse, but these patients are difficult to treat as the cancer ...

Oncology & Cancer

Neurotoxicity of chemotherapy drugs

Chemotherapy is one of the primary treatments for cancer. However, one of the most disturbing findings of recent studies of cancer survivors is the apparent prevalence of chemotherapy-associated adverse neurological effects, ...

Oncology & Cancer

Developments in TACE and SIRT treatment in patients

Data from a number of clinical trials presented today at the International Liver Congress 2013 shed new light on the use of TACE and SIRT in the treatment of hepatocellular carcinoma (HCC).

Oncology & Cancer

New imaging process provides better picture of tumours

Cancer remains one of the leading causes of death in Europe and the world, and early detection and treatment remains vital in the fight. Researchers in Norway have validated a method of non-invasive imaging that they believe ...

page 9 from 12